ArticleOncoimmunology2023

C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer.

Chen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.